Regeneron Pharmaceuticals (REGN) to Release Quarterly Earnings on Tuesday
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) will likely be posting its Q1 2025 quarterly earnings results before the market opens on Tuesday, April 29th. Analysts expect Regeneron Pharmaceuticals to post earnings of $8.83 per share and revenue of $3.40 billion for the quarter. Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) last released its quarterly […]
